Cargando…
Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
Mesenchymal stem cell (MSC) therapy is a promising approach to curing bone diseases and disorders. In treating genetic bone disorders, MSC therapy is local or systemic transplantation of isolated and in vitro proliferated MSC rather than bone marrow transplantation. Recent evidence showed that bone...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020919/ https://www.ncbi.nlm.nih.gov/pubmed/36936364 http://dx.doi.org/10.1002/jbm4.10722 |
_version_ | 1784908366614626304 |
---|---|
author | Kawai, Hotaka Oo, May Wathone Takabatake, Kiyofumi Tosa, Ikue Soe, Yamin Eain, Htoo Shwe Sanou, Sho Fushimi, Shigeko Sukegawa, Shintaro Nakano, Keisuke Takeshi, Takarada Nagatsuka, Hitoshi |
author_facet | Kawai, Hotaka Oo, May Wathone Takabatake, Kiyofumi Tosa, Ikue Soe, Yamin Eain, Htoo Shwe Sanou, Sho Fushimi, Shigeko Sukegawa, Shintaro Nakano, Keisuke Takeshi, Takarada Nagatsuka, Hitoshi |
author_sort | Kawai, Hotaka |
collection | PubMed |
description | Mesenchymal stem cell (MSC) therapy is a promising approach to curing bone diseases and disorders. In treating genetic bone disorders, MSC therapy is local or systemic transplantation of isolated and in vitro proliferated MSC rather than bone marrow transplantation. Recent evidence showed that bone marrow MSC engraftment to bone regeneration has been controversial in animal and human studies. Here, our modified bone marrow transplantation (BMT) method solved this problem. Like routine BMT, our modified method involves three steps: (i) isolation of bone marrow cells from the donor, (ii) whole‐body lethal irradiation to the recipient, and (iii) injection of isolated bone marrow cells into irradiated recipient mice via the tail vein. The significant modification is imported at the bone marrow isolation step. While the bone marrow cells are flushed out from the bone marrow with the medium in routine BMT, we applied the enzymes’ (collagenase type 4 and dispase) integrated medium to wash out the bone marrow cells. Then, cells were incubated in enzyme integrated solution at 37°C for 10 minutes. This modification designated BMT as collagenase‐integrated BMT (c‐BMT). Notably, successful engraftment of bone marrow MSC to the new bone formation, such as osteoblasts and chondrocytes, occurs in c‐BMT mice, whereas routine BMT mice do not recruit bone marrow MSC. Indeed, flow cytometry data showed that c‐BMT includes a higher proportion of LepR(+), CD51(+), or RUNX2(+) non‐hematopoietic cells than BMT. These findings suggested that c‐BMT is a time‐efficient and more reliable technique that ensures the disaggregation and collection of bone marrow stem cells and engraftment of bone marrow MSC to the recipient. Hence, we proposed that c‐BMT might be a promising approach to curing genetic bone disorders. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. |
format | Online Article Text |
id | pubmed-10020919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100209192023-03-18 Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells Kawai, Hotaka Oo, May Wathone Takabatake, Kiyofumi Tosa, Ikue Soe, Yamin Eain, Htoo Shwe Sanou, Sho Fushimi, Shigeko Sukegawa, Shintaro Nakano, Keisuke Takeshi, Takarada Nagatsuka, Hitoshi JBMR Plus Research Articles Mesenchymal stem cell (MSC) therapy is a promising approach to curing bone diseases and disorders. In treating genetic bone disorders, MSC therapy is local or systemic transplantation of isolated and in vitro proliferated MSC rather than bone marrow transplantation. Recent evidence showed that bone marrow MSC engraftment to bone regeneration has been controversial in animal and human studies. Here, our modified bone marrow transplantation (BMT) method solved this problem. Like routine BMT, our modified method involves three steps: (i) isolation of bone marrow cells from the donor, (ii) whole‐body lethal irradiation to the recipient, and (iii) injection of isolated bone marrow cells into irradiated recipient mice via the tail vein. The significant modification is imported at the bone marrow isolation step. While the bone marrow cells are flushed out from the bone marrow with the medium in routine BMT, we applied the enzymes’ (collagenase type 4 and dispase) integrated medium to wash out the bone marrow cells. Then, cells were incubated in enzyme integrated solution at 37°C for 10 minutes. This modification designated BMT as collagenase‐integrated BMT (c‐BMT). Notably, successful engraftment of bone marrow MSC to the new bone formation, such as osteoblasts and chondrocytes, occurs in c‐BMT mice, whereas routine BMT mice do not recruit bone marrow MSC. Indeed, flow cytometry data showed that c‐BMT includes a higher proportion of LepR(+), CD51(+), or RUNX2(+) non‐hematopoietic cells than BMT. These findings suggested that c‐BMT is a time‐efficient and more reliable technique that ensures the disaggregation and collection of bone marrow stem cells and engraftment of bone marrow MSC to the recipient. Hence, we proposed that c‐BMT might be a promising approach to curing genetic bone disorders. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2023-02-11 /pmc/articles/PMC10020919/ /pubmed/36936364 http://dx.doi.org/10.1002/jbm4.10722 Text en © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Kawai, Hotaka Oo, May Wathone Takabatake, Kiyofumi Tosa, Ikue Soe, Yamin Eain, Htoo Shwe Sanou, Sho Fushimi, Shigeko Sukegawa, Shintaro Nakano, Keisuke Takeshi, Takarada Nagatsuka, Hitoshi Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells |
title | Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells |
title_full | Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells |
title_fullStr | Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells |
title_full_unstemmed | Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells |
title_short | Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells |
title_sort | enzyme‐cleaved bone marrow transplantation improves the engraftment of bone marrow mesenchymal stem cells |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020919/ https://www.ncbi.nlm.nih.gov/pubmed/36936364 http://dx.doi.org/10.1002/jbm4.10722 |
work_keys_str_mv | AT kawaihotaka enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT oomaywathone enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT takabatakekiyofumi enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT tosaikue enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT soeyamin enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT eainhtooshwe enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT sanousho enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT fushimishigeko enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT sukegawashintaro enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT nakanokeisuke enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT takeshitakarada enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells AT nagatsukahitoshi enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells |